KR20150050500A - Spherical hydrogel particles using MPC and water-soluble crosslinking agent PEG-diacrylate - Google Patents
Spherical hydrogel particles using MPC and water-soluble crosslinking agent PEG-diacrylate Download PDFInfo
- Publication number
- KR20150050500A KR20150050500A KR1020140149695A KR20140149695A KR20150050500A KR 20150050500 A KR20150050500 A KR 20150050500A KR 1020140149695 A KR1020140149695 A KR 1020140149695A KR 20140149695 A KR20140149695 A KR 20140149695A KR 20150050500 A KR20150050500 A KR 20150050500A
- Authority
- KR
- South Korea
- Prior art keywords
- mpc
- spherical hydrogel
- water
- emulsion
- crosslinking agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 91
- 239000002245 particle Substances 0.000 title claims abstract description 59
- 239000003431 cross linking reagent Substances 0.000 title claims description 26
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 title description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 24
- -1 methacryloyl phosphoryl Chemical group 0.000 claims abstract description 8
- 229950004354 phosphorylcholine Drugs 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 55
- 239000000839 emulsion Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000012071 phase Substances 0.000 claims description 25
- 239000004094 surface-active agent Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 18
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 238000004132 cross linking Methods 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 229940008099 dimethicone Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 229920005650 polypropylene glycol diacrylate Polymers 0.000 claims description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 3
- 125000004386 diacrylate group Chemical group 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims 2
- OPDBGKQXNHUHTA-UHFFFAOYSA-O CC(=C)C(=O)P(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)P(=O)=C(O)C[N+](C)(C)C OPDBGKQXNHUHTA-UHFFFAOYSA-O 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 16
- 239000007863 gel particle Substances 0.000 abstract description 3
- 239000007762 w/o emulsion Substances 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 description 34
- 230000000052 comparative effect Effects 0.000 description 16
- 239000003921 oil Substances 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 238000001035 drying Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000010102 embolization Effects 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/32—Polymerisation in water-in-oil emulsions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
본 발명은 메타크릴로일 포스포릴콜린(Methacryloyl phosphoryl choline, MPC) 구형 하이드로겔 입자에 관한 것으로, 더욱 상세하게는 MPC와 수용성 가교제를 이용하여 유중수형(w/o) 에멀젼의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법에 관한 것이다.The present invention relates to a methacryloyl phosphoryl choline (MPC) spherical hydrogel particle, and more particularly, to a hydrogel particle made of an aqueous solution of a water-in-oil (w / o) emulsion using MPC and a water- Gel particles and a method for producing the same.
Description
본 발명은 메타크릴로일 포스포릴콜린(Methacryloyl phosphoryl choline, MPC) 구형 하이드로겔 입자에 관한 것으로, 더욱 상세하게는 MPC와 수용성 가교제를 이용하여 유중수형(w/o) 에멀젼의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법에 관한 것이다.
The present invention relates to a methacryloyl phosphoryl choline (MPC) spherical hydrogel particle, and more particularly, to a hydrogel particle made of an aqueous solution of a water-in-oil (w / o) emulsion using MPC and a water- Gel particles and a method for producing the same.
1980년대 후반에서 1990년대까지 하이드로겔 입자에 관한 연구는 고분자 재료를 마이크로 크기로 입자화하고 표면 및 내부를 화학적으로 개질함으로써 색전술(embolization), 효소고정화(enzyme immobilization), 약물전달(drug delivery) 등의 분야에 응용되어 왔다. 2000년대에 진입하면서는 나노기술의 발달과 더불어 수용성 고분자를 이용한 나노크기의 입자 제조 및 응용에 관한 연구가 진행되고 있다. 현재까지 하이드로겔 입자에 관한 대부분의 연구는 바이오신약 및 바이오장기 분야에 응용을 목적으로 하여 생분해성 고분자를 사용하며, 비침습적(non-invasive) 시술을 위해 주입가능형(injectable) 구조로 제조하는 것에 집중되고 있다. 상기 분야는 약물전달시스템, 색전술, 조직공학용 스캐폴드, 벌킹 에이전트(bulking agent) 및 임플란트(implant) 등을 포함한다. 이밖에 단백질의 분리, 농축 및 안정화, 면역검정(immunoassay), 바이오리액터(bioreactor), 센서, 바이오스페시픽(biospecific) 크로마토그래피, 화장품 충진제(cosmetic filler) 등의 분야에도 폭넓게 사용되고 있다. 이러한 하이드로겔 입자는 에멀젼화, 코아세르베이션, 분무 건조 등의 물리적 방법 및 불균일계 중합과 같은 화학적 방법으로 만들어진다. 그 한가지 예로 w/o 에멀젼을 이용하여 계면에서 일어나는 가교반응을 통하여 다당류로 구성된 벽을 가지는 마이크로캡슐의 제조를 들 수 있다(M.C. Levy et al., Int. J. Pharm., 62, 1990, 27-35; PCT/FR93/00237). 상기 방법은 w/o 에멀젼에서 가교제를 함유하는 오일상과 다당류를 함유하는 수상이 접촉하는 계면에서 발생하는 계면가교 반응을 통해서 계면부분만이 가교된, 수 마이크론 이상의 크기를 가지는 마이크로캡슐을 얻는 방법이다. Studies of hydrogel particles from the late 1980s to the 1990s have shown that the polymer material can be micro-sized and chemically modified on the surface and inside to form embolization, enzyme immobilization, drug delivery, etc. Has been applied in the field of. With the development of nanotechnology in the 2000s, studies on the manufacture and application of nano-sized particles using water-soluble polymers are underway. Most studies on hydrogel particles to date have used biodegradable polymers for applications in biopharmaceuticals and bio-organs, and they have been made into injectable structures for non-invasive procedures Is focused on. The field includes drug delivery systems, embolization, scaffolds for tissue engineering, bulking agents and implants, and the like. In addition, it is widely used in the fields of protein separation, concentration and stabilization, immunoassay, bioreactor, sensor, biospecific chromatography, and cosmetic filler. These hydrogel particles are made by chemical methods such as physical methods such as emulsification, coacervation, spray drying, and heterogeneous polymerization. One example is the preparation of microcapsules with walls composed of polysaccharides through a cross-linking reaction at the interface using a w / o emulsion (MC Levy et al., Int. J. Pharm., 62, 1990, 27 -35; PCT / FR93 / 00237). This method is a method for obtaining a microcapsule having a size of several microns or more in which only the interface portion is crosslinked through an interfacial crosslinking reaction occurring at the interface between the oily phase containing a crosslinking agent and the polysaccharide-containing interface in the w / o emulsion to be.
종래에는 카르보디이미드 가교제(carbodiimide crosslinker)를 사용하여, MPC와 PEG-디아크릴레이트를 가교시키고, 하이드로겔을 제조할 수 있다고 밝혀졌으나, 유중수 에멀젼의 수상 용액에서 하이드로겔을 제조하는 방법은 개시되지 않았고(국제특허공개 WO2011/038485), PEG-디아크릴레이트를 가교시킨 MPC를 이용한 고분자 네트워크에 대하여 연구되었으나, 역시 w/o 에멀젼의 수상 용액에서 하이드로겔을 제조하는 방법은 개시되지 않았다(“Collagen-phosphorylcholine interpenetrating networkhydrogels as corneal substitutes”, Wenguang Liu et al., Biomaterials 30 (2009) 1551-1559). 이러한 종래 방법들에 의해 형성된 MPC 하이드로겔은 부피가 큰 무정형의 하이드로겔 형태에 한정되어 있어 화장품 용도로 사용하기 어렵다는 한계가 있었다.
It has been found that a hydrogel can be prepared by cross-linking MPC with PEG-diacrylate using a carbodiimide crosslinker. However, a method for producing a hydrogel in an aqueous solution of a water- (International Patent Publication No. WO2011 / 038485), a polymer network using MPC crosslinked with PEG-diacrylate has been studied, but no method for producing a hydrogel in an aqueous solution of w / o emulsion has been disclosed Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes ", Wenguang Liu et al., Biomaterials 30 (2009) 1551-1559). The MPC hydrogels formed by these conventional methods are limited to the form of amorphous hydrogel having a large volume, which is difficult to use for cosmetic applications.
이에, 본 발명자들은 종래의 문제점을 해결하기 위하여 제조상의 여러 변수들을 조절하면서 w/o 에멀젼의 수상 용액에 존재하는 MPC를 화학적으로 가교시켜 MPC 구형 하이드로겔 입자를 제조하는 연구를 진행하였다. 구체적으로 오일의 종류, w/o 에멀젼의 오일상 용액과 수상 용액의 비율, 계면활성제의 종류 및 농도 등을 제조상의 변수들로 정하였다.The inventors of the present invention conducted studies to prepare MPC spherical hydrogel particles by chemically crosslinking MPC present in the aqueous solution of the w / o emulsion while adjusting various parameters in manufacturing to solve the conventional problems. Specifically, the type of oil, the ratio of the oily solution to the aqueous solution of the w / o emulsion, the kind and concentration of the surfactant, and the like were determined as manufacturing parameters.
그 결과, MPC와 특정 수용성 가교제를 이용하여 구형으로 하이드로겔 입자를 제조하는 경우, 기존 제조 방법들에 의해 형성된 MPC 하이드로겔보다 수분감이 매우 향상되고, 계면활성제 없이도 에멀젼 상에 쉽게 분산이 가능함을 발견하고 본 발명을 완성하였다. As a result, it was found that when the spherical hydrogel particles were prepared using MPC and a specific water-soluble crosslinking agent, the moisture sensitivity was much improved than that of the MPC hydrogels formed by the conventional manufacturing methods and that they could be easily dispersed on the emulsion phase without the surfactant And completed the present invention.
따라서, 본 발명은 향상된 수분감을 가지며, 에멀젼 상에의 분산이 용이한 MPC 구형 하이드로겔 입자 및 이의 제조방법을 제공하는데 그 목적이 있다.
Accordingly, it is an object of the present invention to provide an MPC spherical hydrogel particle having an improved moisture sensitivity and being easily dispersed in an emulsion, and a method for producing the same.
상기와 같은 목적을 달성하기 위하여, 본 발명은 MPC와 수용성 가교제를 이용하여 w/o 에멀젼의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법을 제공한다.
In order to achieve the above object, the present invention provides a hydrogel particle made from an aqueous solution of a w / o emulsion using MPC and a water-soluble crosslinking agent and a method for producing the same.
본 발명은 MPC와 특정 수용성 가교제를 이용하여 w/o 에멀젼의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법에 관한 것으로, 제조된 MPC 구형 하이드로겔은 크기가 작은 구형의 젤 입자 형태로 동일한 형태와 크기의 입자가 형성되기 때문에(30~50μm), 기존의 MPC 하이드로겔보다 수분감이 매우 향상되며, 계면활성제 없이 에멀젼 상에 분산이 가능하여, 화장품 등에 쉽게 이용될 수 있다.
The present invention relates to a hydrogel particle made from an aqueous solution of a w / o emulsion using MPC and a specific water-soluble crosslinking agent and a method for producing the same. The MPC spherical hydrogel is in the form of a spherical gel particle of the same size, (30 to 50 μm), the moisture sensitivity of the present invention is significantly improved compared with that of conventional MPC hydrogels, and it can be dispersed on an emulsion without a surfactant, and thus can be easily used in cosmetics and the like.
도 1은 본 발명에 따른 MPC 구형 하이드로겔을 오일상 용액에 분산시켰을때, 계면활성제 없이 안정하게 분산됨을 나타낸 사진이다.
도 2는 본 발명에 따른 MPC 구형 하이드로겔이 w/o, o/w 제형에 모두 안정하게 분산됨을 나타낸 현미경 사진이다.
도 3은 MPC 구형 하이드로겔의 건조 전과 건조 후의 크기 변화를 나타낸 현미경 사진이다.
도 4는 w/o에 본 발명에 따른 MPC 구형 하이드로겔 첨가에 따른 수분 증감율 변화를 나타낸 그래프이다.FIG. 1 is a photograph showing that when the MPC spherical hydrogel according to the present invention is dispersed in an oily phase solution, it is dispersed stably without using a surfactant.
Figure 2 is a micrograph showing that the MPC spherical hydrogel according to the present invention is stably dispersed in both w / o and o / w formulations.
3 is a photomicrograph showing the size change of the MPC spherical hydrogel before drying and after drying.
FIG. 4 is a graph showing changes in moisture change rate according to the addition of the MPC spherical hydrogel according to the present invention to w / o.
본 발명은 MPC와 특정 수용성 가교제를 이용하여 w/o 에멀젼의 수상 용액에서 만들어진 구형 하이드로겔 입자 및 이의 제조방법에 관한 것이다.The present invention relates to spherical hydrogel particles made in an aqueous solution of a w / o emulsion using MPC and a specific water-soluble crosslinking agent and a method for producing the same.
이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.
본 발명에 따른 MPC와 수용성 가교제를 이용한 구형 하이드로겔 입자를 제조하는 방법은 The method for producing spherical hydrogel particles using MPC and the water-soluble crosslinking agent according to the present invention
a) 오일성분에 계면활성제를 용해시켜 오일상 용액을 제조하는 단계;a) dissolving a surfactant in an oil component to prepare an oily phase solution;
b) MPC 및 수용성 가교제를 용매에 용해시켜 수상 용액을 제조하는 단계;b) dissolving MPC and a water-soluble crosslinking agent in a solvent to prepare an aqueous solution;
c) 상기 a)의 용액에 상기 b)의 용액을 투입하여 w/o 에멀젼을 형성하는 단계;c) adding the solution of b) to the solution of a) to form a w / o emulsion;
d) 상기 c)의 w/o 에멀젼을 40~150℃로 가열하면서 수상 용액 상의 가교제와 MPC와의 가교반응을 진행시키는 단계; 및d) heating the w / o emulsion of c) at 40 to 150 캜 to proceed a crosslinking reaction between the crosslinking agent and the MPC on the aqueous solution; And
e) 상기 d)의 w/o 에멀젼으로부터 MPC 구형 하이드로겔 입자를 회수하는 단계를 포함하는 것을 특징으로 한다. e) recovering the MPC spherical hydrogel particles from the w / o emulsion of d).
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 오일성분으로는 식물성, 광물성, 실리콘유 및 합성유로 이루어진 군으로부터 1종 이상 선택하여 사용할 수 있으며, 바람직하게는 세틸 에틸헥사노에이트(Cetyl ethyl hexanoate, CEH), 도데칸(Dodecane), 헵탄(Heptane) 등을 사용할 수 있다. The oil component used for preparing the MPC spherical hydrogel particles according to the present invention may be selected from the group consisting of vegetable, mineral, silicone oil and synthetic oil, preferably cetyl ethylhexanoate ethyl hexanoate, CEH, dodecane, heptane and the like.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 계면활성제로는 일반적으로 w/o 에멀젼을 안정화시킬 수 있는 계면활성제들 중에서 1종 이상 선택하여 사용할 수 있으며, 바람직하게는 세틸 PEG/PPG-10/1 디메치콘(Cetyl PEG/PPG-10/1 dimethicone (ABIL EM-90)), 소르비탄 세스퀴올레이트(Sorbitan sesquioleate (ARLACEL 83)), 폴리에틸렌 글리콜 디폴리하이드록시 스테아레이트(Polyethylene glycol dipolyhydroxy stearate (ARLACEL P135))등을 사용할 수 있다.As the surfactant used for preparing the MPC spherical hydrogel particles according to the present invention, at least one surfactant capable of stabilizing the w / o emulsion can be generally used, and preferably cetyl PEG / PPG (PEG / PPG-10/1 dimethicone (ABIL EM-90)), sorbitan sesquioleate (ARLACEL 83), polyethylene glycol dipolyhydroxy stearate stearate (ARLACEL P135)) can be used.
본 발명에서 상기 계면활성제의 함량은 w/o 에멀젼의 오일상과 수상의 혼합액 총 중량에 대하여 1~10중량%이며, 바람직하게는 2~6중량%이다. 상기 계면활성제의 농도는 w/o 에멀젼 입자의 크기와 안정도에 영향을 주는 요인으로, 1중량% 미만이면 입자들의 크기가 증가하고 입자의 안정도가 불안정해지며, 10중량% 초과이면 w/o 에멀젼 입자는 안정화되지만, 최종적으로 얻어지는 입자에서 계면활성제는 필요없는 불순물 성분이 되므로 순도가 낮아지는 단점이 있다.In the present invention, the content of the surfactant is 1 to 10% by weight, preferably 2 to 6% by weight based on the total weight of the mixture of the oil phase and water phase of the w / o emulsion. The concentration of the surfactant influences the size and stability of the w / o emulsion particle. If the concentration is less than 1% by weight, the particle size increases and the stability of the particle becomes unstable. If the concentration exceeds 10% by weight, The particles are stabilized, but the purity is lowered because the surfactant becomes an impurity component which is not necessary in the finally obtained particles.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 있어서, 수상 용액의 제조에 사용되는 용매는 특별히 한정되는 것은 아니지만, 바람직하게는 정제수이다.In the production of the MPC spherical hydrogel particles according to the present invention, the solvent used for preparing the aqueous solution is not particularly limited, but is preferably purified water.
본 발명에 있어서, MPC(Methacryloyl phosphoryl choline)는 오일상과 수상의 혼합액 총 중량에 대하여 0.1~20 중량%의 양으로 사용된다.In the present invention, MPC (Methacryloyl phosphoryl choline) is used in an amount of 0.1 to 20% by weight based on the total weight of the mixture of oil phase and water phase.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 수용성 가교제로는 천연고분자 다당류와 가교결합을 형성하는 특징을 가지는 가교제들로부터 1종 이상 선택하여 사용할 수 있다. 상기 가교제로서 비스에폭시드를 사용하면 기존에 에스터화반응(esterfication)을 통해 많이 사용되던 가교결합인 에스터(ester)결합이 아닌 에테르(ether)결합을 형성하게 된다. 또한 가교된 구조가 물에 분산되었을 경우 가교구조를 이루는 성분들이 물과 좀 더 친한 성격을 가지게 하기 위하여 PEG 체인(chain)을 가교제의 주쇄로 사용하는 것을 고려하여, 본 발명에서는 특히 폴리프로필렌 글리콜 디아크릴레이트(Polypropylene glycol diacrylate, PPG-DA) 또는 폴리에틸렌 글리콜 디아크릴레이트(Polyethylene glycol diacrylate, PEG-DA)가 바람직하며, 폴리에틸렌 글리콜 디아크릴레이트를 사용하는 것이 보다 바람직하다. 상기 물질로 가교된 MPC 구형 하이드로겔 입자는 수상에서 빠르고 높은 팽윤도를 보인다. The water-soluble crosslinking agent used for preparing the MPC spherical hydrogel particles according to the present invention may be selected from at least one crosslinking agent having a characteristic of forming a crosslinking with a natural high-molecular polysaccharide. When bis epoxide is used as the cross-linking agent, an ether bond is formed rather than an ester bond, which is a cross-linkage which is conventionally used through esterification. Considering the use of a PEG chain as a main chain of a cross-linking agent in order to make the components forming the cross-linking structure more closely related to water when the cross-linked structure is dispersed in water, in the present invention, especially, polypropylene glycol di Polypropylene glycol diacrylate (PPG-DA) or polyethylene glycol diacrylate (PEG-DA) is preferable, and polyethylene glycol diacrylate is more preferably used. The MPC spherical hydrogel particles crosslinked with the above material exhibit a fast and high swelling in the water phase.
본 발명에서 상기 수용성 가교제는 오일상과 수상의 혼합액 총 중량에 대하여 0.1~10중량%의 양으로 사용된다.In the present invention, the water-soluble crosslinking agent is used in an amount of 0.1 to 10% by weight based on the total weight of the mixed liquid of oil phase and water phase.
또한, 본 발명에서 상기 MPC와 수용성 가교제는 1:9의 중량 비율로 혼합되는 것이 바람직하다.In the present invention, it is preferable that the MPC and the water-soluble cross-linking agent are mixed in a weight ratio of 1: 9.
본 발명에 있어서, w/o 에멀젼을 구성하는데 사용되는 계면활성제가 용해된 오일상 용액 및 MPC 및 수용성 가교제가 용해된 수상 용액의 혼합비율은 중량기준으로 오일상 용액 : 수상 용액 = 1:1~7:3인 것이 바람직하다.In the present invention, the mixing ratio of the oily phase solution in which the surfactant used to constitute the w / o emulsion is dissolved and the aqueous solution in which the MPC and the water soluble crosslinking agent are dissolved is in the range of 1: 7: 3.
상기 e)의 MPC 구형 하이드로겔 입자의 회수는 가교반응이 완료된 에멀젼을 유기용매로 세척한 다음, 수상 용액 상의 MPC 구형 하이드로겔 입자를 취득하고, 이를 70~90℃에서 진공 건조하여 잔류 유기용매를 제거하는 단계로 이루어진다.The recovery of the MPC spherical hydrogel particles in e) is carried out by washing the emulsion after completion of the crosslinking reaction with an organic solvent, and then obtaining MPC spherical hydrogel particles on the aqueous solution, drying it at 70 to 90 ° C under vacuum, .
상기 유기용매는 물에 혼합 가능한 것이면 제한되지 않지만, 에탄올, 메탄올, 아이소프로필알코올, 아세톤, 테트라하이드로퓨란으로부터 선택되는 것이 바람직하다. The organic solvent is not limited as long as it can be mixed with water, but is preferably selected from ethanol, methanol, isopropyl alcohol, acetone, and tetrahydrofuran.
선택적으로, 유기용매를 이용하여 세척된 MPC 구형 하이드로겔 입자들에 존재할 수 있는 오일, 계면활성제, 미반응 가교제 등의 불순물을 완벽하게 제거하기 위하여, 세척된 MPC 구형 하이드로겔 입자가 분산된 수용액을 만들고, 이를 유기용매를 이용하여 세척하는 단계가 더 포함될 수 있다.Alternatively, in order to completely remove impurities such as oils, surfactants, and unreacted crosslinking agents that may be present in the MPC spherical hydrogel particles washed with an organic solvent, an aqueous solution in which washed MPC spherical hydrogel particles are dispersed And then washing it with an organic solvent.
상기의 제조방법을 통해 얻어지는 MPC 구형 하이드로겔 입자는 가교제의 종류 및 농도, w/o 에멀젼의 수상 용액과 오일상 용액의 비율, w/o 에멀젼에 사용되는 오일의 종류, 계면활성제의 종류 및 농도 등의 제조상의 변수들을 조절함에 따라 건조한 상태에서 수십에서 수백 나노미터의 입자크기를 가질 수 있다. The MPC spherical hydrogel particles obtained through the above-mentioned production method can be obtained by various methods such as the type and concentration of the crosslinking agent, the ratio of the aqueous solution and oily solution of the w / o emulsion, the kind of the oil used for the w / o emulsion, The particle size can be in the range of tens to hundreds of nanometers in the dry state.
본 발명에 따라 제조되는 MPC 구형 하이드로겔 입자는 오일, w/o 또는 o/w 등의 유화 조성물에 계면활성제 없이도 안정적으로 분산될 수 있으며, 따라서 화장료 조성물 등의 피부 외용제 조성물에서 효율적으로 활용될 수 있다.The MPC spherical hydrogel particles prepared according to the present invention can be stably dispersed in an emulsified composition such as oil, w / o or o / w without a surfactant, and thus can be efficiently used in a composition for skin external application such as a cosmetic composition have.
본 발명의 MPC 구형 하이드로겔 입자가 피부 외용제 조성물에서 사용될 경우, 의도하는 목적 및 용도에 따라서 함량이 달라질 수 있으나, 바람직하게는 조성물 총 중량에 대하여 대략 20 중량%의 양으로 사용될 수 있다.
When the MPC spherical hydrogel particles of the present invention are used in a composition for external application for skin, they may be used in an amount of about 20% by weight based on the total weight of the composition, although the content may vary depending on the intended purpose and use.
본 발명은 하기 실시예 및 시험예에 의하여 더욱 구체적으로 설명한다. 그러나, 하기 실시예 및 시험예는 본 발명에 대한 이해를 돕기 위한 것일 뿐, 어떤 의미로든 본 발명의 범위가 이러한 실시예 및 시험예에 의하여 한정되는 것은 아니다.
The present invention will be described in more detail with reference to the following examples and test examples. However, the following examples and test examples are provided to aid understanding of the present invention, and the scope of the present invention is not limited in any way by these examples and test examples.
[참고예 1] MPC 하이드로겔의 제조[Referential Example 1] Preparation of MPC hydrogel
하기 표 1에 기재된 조성으로 실시예 1~2 및 비교예 1의 하이드로겔을 제조하였다(중량부). 구체적으로, 실시예 1~2는 본 발명에 따라서 w/o 에멀젼의 수상 용액에서 제조한 것이고, 비교예 1은 수상에서 제조한 하이드로겔이다.The hydrogels of Examples 1 and 2 and Comparative Example 1 were prepared in the composition shown in Table 1 below (parts by weight). Specifically, Examples 1 and 2 are prepared in an aqueous solution of a w / o emulsion according to the present invention, and Comparative Example 1 is a hydrogel prepared in an aqueous phase.
<제조방법 - 실시예 1 및 2>≪ Preparation method-Examples 1 and 2 >
1) 헥산에 계면활성제인 PEG-30 디폴리하이드록시 스테아레이트를 혼합하여 오일상 용액을 제조하였다.1) An oily solution was prepared by mixing hexane with PEG-30 dipolyhydroxy stearate, a surfactant.
2) 정제수에 MPG, 및 PEG-DA 또는 PPG-DA를 혼합하여 수상 용액을 제조한다.2) MPG, and PEG-DA or PPG-DA are mixed with purified water to prepare an aqueous solution.
3) 1)의 용액에 2)의 용액을 천천히 첨가하면서 유화기로 1800~2000rpm의 속도로 10분간 혼합 교반시켜 에멀젼을 제조한다.3) To the solution of 1), the emulsion is prepared by slowly stirring the solution of 2) and mixing and stirring for 10 minutes at a speed of 1800 to 2000 rpm in an emulsifier.
4) 에멀젼이 유지되도록 1800~2000rpm으로 교반하면서 70℃에서 가열하여 가교 반응을 진행한다.4) The crosslinking reaction is carried out by heating at 70 ° C with stirring at 1800 to 2000 rpm so as to keep the emulsion.
5) 반응을 마친 에멀젼을 아이소프로필알코올에 침전을 시키고 침전된 MPC 구형 하이드로겔 입자를 분리한다.5) After the reaction, the precipitated emulsion is precipitated in isopropyl alcohol and the precipitated MPC spherical hydrogel particles are separated.
6) 5)의 분리한 MPC 구형 하이드로겔 입자가 분산된 수용액을 만들어 다시 아이소프로필알코올에 침전시켜 잔존하는 오일, 계면활성제, 미반응 가교제 등의 불순물을 제거한다.6) 5) are separated and precipitated in isopropyl alcohol to remove impurities such as residual oil, surfactant, and unreacted crosslinking agent.
7) 얻은 MPC 구형 하이드로겔 입자들을 70~90℃에서 24시간 동안 진공건조를 시켜 잔류 용매를 완벽하게 제거한다.
7) The obtained MPC spherical hydrogel particles are vacuum-dried at 70 to 90 ° C for 24 hours to completely remove the residual solvent.
<제조방법 - 비교예 1><Manufacturing method-Comparative example 1>
MPC와 PEG-DA를 물에 용해 시킨후 70℃에서 가온 반응시킨다.
MPC and PEG-DA are dissolved in water and heated at 70 ° C.
[참조예 2] MPC 하이드로겔을 포함하는 조성물의 제조[Reference Example 2] Preparation of a composition containing MPC hydrogel
하기 표 2 및 3에 기재된 조성으로 제형예 1 내지 4, 비교제형예 1 및 2의 하이드로겔을 제조하였다(중량%). 구체적으로, 제형예 1 및 2는 w/o 제형으로서 각각 실시예 1 및 2의 하이드로겔을 포함하는 것이고, 제형예 3 및 4는 o/w 제형으로서 각각 실시예 1 및 2의 하이드로겔을 포함하는 것이다. 또한, 비교제형예 1 및 2는 비교예 1의 하이드로겔을 포함하는 w/o 및 o/w 제형의 조성물이다.Hydrogels of Formulation Examples 1 to 4 and Comparative Formulation Examples 1 and 2 were prepared (wt%) in the compositions shown in Tables 2 and 3 below. Specifically, Formulation Examples 1 and 2 include the hydrogels of Examples 1 and 2 as w / o formulations, respectively, and Formulations 3 and 4 contain the hydrogels of Examples 1 and 2 as o / w formulations, respectively . In addition, Comparative Formulation Examples 1 and 2 are compositions of the w / o and o / w formulations containing the hydrogel of Comparative Example 1.
제형예1compare
Formulation Example 1
제형예2compare
Formulation Example 2
제형예3compare
Formulation Example 3
[시험예 1] MPC 구형 하이드로겔의 특성[Test Example 1] Properties of MPC spherical hydrogel
단일 오일상(하이드로제네이티드 폴리데센 이용)에 실시예 1~2 또는 비교예 1의 MPC 하이드로겔, 또는 하이드로겔과 동량의 물을 분산시킨 다음 분산 상태를 관찰하였으며, 실시예 1에 대하여 측정한 현미경 사진 및 비교예 1에 대하여 육안으로 관찰한 사진을 도 1에 나타내었다. 또한, w/o 또는 o/w 제형의 조성물에 본 발명에 따른 하이드로겔 입자를 분산시킨 상기 제형예 1~4, 및 비교제형예 1 및 3의 분산 상태를 측정하였으며, 제형예 1 및 3에 대하여 측정한 현미경 사진을 도 2에 나타내었다. The MPC hydrogel of Examples 1 to 2 or Comparative Example 1, or the same amount of water as that of the hydrogel was dispersed in a single oil phase (using a hydrogenated polydecene), and then the dispersion state was observed. A micrograph and a photograph of the comparative example 1 observed with naked eyes are shown in Fig. In addition, the dispersion states of Formulation Examples 1 to 4 and Comparative Formulation Examples 1 and 3 in which the hydrogel particles according to the present invention were dispersed in the composition of w / o or o / w formulation were measured, and Formulation Examples 1 and 3 2 is a micrograph of the sample.
단일 오일상에 실시예 1 또는 실시예 2를 분산시킨 경우에는 2가지 경우 모두 하이드로겔 입자가 안정적으로 분산하였다. 특히 실시예 1의 하이드로겔 입자의 분산 상태를 나타낸 도 1을 살펴보면, 오일상 용액에 본 발명에 따라 제조한 MPC 구형 하이드로겔 분산시에는 계면활성제 없이 안정하게 분산되었으나, 오일상에 같은 양의 물을 첨가한 경우는 분리가 일어남을 확인할 수 있다. 또한, 비교예 1의 MPC 하이드로겔 분산시에는 계면활성제를 사용하지 않으면 분산이 되지 않는다는 것을 확인할 수 있다.When Example 1 or Example 2 was dispersed on a single oil, the hydrogel particles were stably dispersed in both cases. 1 showing the dispersion state of the hydrogel particles of Example 1, the MPC spherical hydrogel prepared according to the present invention was stably dispersed in the oily phase without the surfactant, but the same amount of water It can be confirmed that the separation occurs. In addition, it can be confirmed that, when the MPC hydrogel of Comparative Example 1 is dispersed, it is not dispersed unless a surfactant is used.
또한, 도 2을 살펴보면, 본 발명에 따라 제조한 MPC 구형 하이드로겔 입자를 분산시킨 제형은 w/o 제형이든 o/w 제형이든 계면활성제를 사용하지 않고서도 분리가 일어나지 않은 상태로 모두 안정하게 분산되었음을 확인할 수 있다.
2, the formulation in which the MPC spherical hydrogel particles prepared according to the present invention are dispersed can be prepared by dispersing all of the dispersions in a state in which the separation is not performed without using a surfactant, whether it is a w / o formulation or an o / w formulation .
[시험예 2] MPC 구형 하이드로겔의 수분량 측정[Test Example 2] Measurement of water content of MPC spherical hydrogel
본 발명에 따른 MPC 구형 하이드로겔 입자의 수분량을 측정하기 위하여, MPC 구형 하이드로겔을 건조시킨 후 할로겐 습도 분석기(Mettler Toledo)를 이용하여 상기 실시예 1의 하이드로겔 입자의 건조 전후의 무게변화를 105℃에서 60분 동안 가열하면서 5분 간격으로 측정하였다. 입자의 크기 변화를 현미경(Olympus, x200)으로 관찰하여 도 3에 나타내었다. In order to measure the water content of the MPC spherical hydrogel particles according to the present invention, the weight change before and after drying of the hydrogel particles of Example 1 was measured using a halogen humidity analyzer (Mettler Toledo) after the MPC spherical hydrogel was dried, Lt; 0 > C for 60 minutes. Changes in particle size were observed with a microscope (Olympus, x200) and are shown in Fig.
MPC 구형 하이드로겔 입자는 건조 후, 8.19±0.16% 잔존하였으며, 이 무게 변화는 MPC 구형 하이드로겔이 약 11.2배의 수분과 결합했다는 것을 나타낸다. 또한, 도 3을 살펴보면, MPC 구형 하이드로겔의 건조 후에는 크기가 현저하게 작아짐을 확인할 수 있는데, 이는 건조과정을 거치면서 MPC 구형 하이드로겔과 결합된 수분량의 감소에 따른 결과임을 알 수 있다.
The MPC spherical hydrogel particles remained 8.19 ± 0.16% after drying, indicating that the MPC spherical hydrogel bound to about 11.2 times the moisture. 3, it can be seen that the size of the MPC spherical hydrogel after drying is remarkably reduced, which is a result of a decrease in the amount of water bound to the MPC spherical hydrogel while being dried.
[시험예 3] MPC 구형 하이드로겔의 보습력 측정[Test Example 3] Measurement of moisture of MPC spherical hydrogel
본 발명에 따른 MPC 구형 하이드로겔 입자의 보습력을 측정하기 위하여, 상기 제형예 1 및 비교제형예 2를 피부에 도포하여 수분량 변화를 측정하였다. 수분량 측정을 위하여, 20~50세 연령의 피험자 10명을 대상으로 양쪽 전박을 비누로 깨끗이 씻은 후, 항온항습조건(20℃, RH 40%)에서 약 15분 동안 피부를 적응시켰다. 수분량 측정 기기(Corneometer®CM825, C+K, 독일)를 이용하여 도포 전의 수분량을 측정하고, 이후 1cm2당 2μl의 양으로 한쪽 전박에는 제형예 1을, 다른쪽 전박에는 비교제형예 2를 고르게 도포 시킨 후, 도포 직후, 1시간 후, 3시간 후의 수분량을 측정하여 증감율을 계산하여 표 4에 나타내었다.In order to measure the moisture resistance of the MPC spherical hydrogel particles according to the present invention, Formulation Example 1 and Comparative Formulation Example 2 were applied to the skin to measure moisture change. For the measurement of water content, the subjects were aged 20 to 50 years old, and then they were cleaned with soap, and the skin was adapted for about 15 minutes under constant temperature and humidity conditions (20 ° C,
상기 표 4에서 알 수 있듯이, 본 발명에 따라 제조된 MPC 구형 하이드로겔을 함유한 제형예 1은 MPC 구형 하이드로겔을 함유하지 않은 비교제형예 2에 비하여, 도포 직후, 도포 1시간 후, 도포 3시간 후에 각각 144.0%, 124.0%, 96.0%의 수치로 수분량이 유의하게 증가하였다. 이는 본 발명에 따른 MPC 구형 하이드로겔은 높은 수분 보유력을 가지며, 이로 인해 다양한 제형에 적용할 경우에 높은 보습력을 구현할 수 있음을 의미한다.As can be seen from Table 4, Formulation Example 1 containing the MPC spherical hydrogel prepared according to the present invention was compared with Comparative Formulation Example 2 containing no MPC spherical hydrogel. Immediately after application, 1 hour after application, After 144 hours, the water content was increased to 144.0%, 124.0% and 96.0%, respectively. This means that the MPC spherical hydrogel according to the present invention has a high water retention ability and thus can realize a high moisture holding ability when applied to various formulations.
Claims (14)
a) 오일성분에 계면활성제를 용해시킨 오일상 용액을 제조하는 단계;
b) MPC 및 수용성 가교제를 용해시킨 수상 용액을 제조하는 단계;
c) 상기 a)의 용액에 상기 b)의 용액을 투입하여 w/o 에멀젼을 형성하는 단계;
d) 상기 c)의 w/o 에멀젼을 40~150℃로 가열하면서 수상 용액 상의 가교제와 MPC와의 가교반응을 진행시키는 단계; 및
e) 상기 d)의 w/o 에멀젼으로부터 MPC 구형 하이드로겔 입자를 회수하는 단계.[Claim 11] The method according to claim 10, wherein the MPC spherical hydrogel particles are prepared by the following steps:
a) preparing an oily phase solution in which a surfactant is dissolved in an oil component;
b) preparing an aqueous solution in which MPC and a water-soluble crosslinking agent are dissolved;
c) adding the solution of b) to the solution of a) to form a w / o emulsion;
d) heating the w / o emulsion of c) at 40 to 150 캜 to proceed a crosslinking reaction between the crosslinking agent and the MPC on the aqueous solution; And
e) recovering the MPC spherical hydrogel particles from the w / o emulsion of d) above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2014/010359 WO2015065100A1 (en) | 2013-10-31 | 2014-10-31 | Spherical hydrogel particles using mpc and water-soluble crosslinking agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130130754 | 2013-10-31 | ||
KR1020130130754 | 2013-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150050500A true KR20150050500A (en) | 2015-05-08 |
KR102163884B1 KR102163884B1 (en) | 2020-10-12 |
Family
ID=53388271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140149695A Active KR102163884B1 (en) | 2013-10-31 | 2014-10-31 | Spherical hydrogel particles using MPC and water-soluble crosslinking agent |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102163884B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022075594A1 (en) * | 2020-10-07 | 2022-04-14 | 주식회사 휴메디솔 | Hand sanitizer based on biocompatible mpc polymer and production method therefor |
WO2023101046A1 (en) * | 2021-12-01 | 2023-06-08 | 주식회사 휴메디솔 | Contact lens solution based on mpc and protease, and method for preparing same |
WO2023101047A1 (en) * | 2021-12-01 | 2023-06-08 | 주식회사 휴메디솔 | Protease-based contact lens cleaning solution and method for preparing same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5562924A (en) | 1992-03-11 | 1996-10-08 | Coletica | Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same |
KR100852944B1 (en) * | 2007-02-15 | 2008-08-19 | (주)아모레퍼시픽 | Method for preparing chemically crosslinked hyaluronic acid hydrogel nanoparticles |
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
KR20130027398A (en) * | 2011-01-07 | 2013-03-15 | 주식회사 케이씨아이 | Crosslinked copolymers based on monomers containing phosphorylcholine-like groups, and their cosmetic formulations |
-
2014
- 2014-10-31 KR KR1020140149695A patent/KR102163884B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5562924A (en) | 1992-03-11 | 1996-10-08 | Coletica | Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same |
KR100852944B1 (en) * | 2007-02-15 | 2008-08-19 | (주)아모레퍼시픽 | Method for preparing chemically crosslinked hyaluronic acid hydrogel nanoparticles |
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
KR20130027398A (en) * | 2011-01-07 | 2013-03-15 | 주식회사 케이씨아이 | Crosslinked copolymers based on monomers containing phosphorylcholine-like groups, and their cosmetic formulations |
Non-Patent Citations (2)
Title |
---|
Biomaterials, 2009년, 30권, 8호, pp1551-1559 * |
Polymer journal, 1990, 22건, 5호, pp355-360 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022075594A1 (en) * | 2020-10-07 | 2022-04-14 | 주식회사 휴메디솔 | Hand sanitizer based on biocompatible mpc polymer and production method therefor |
WO2023101046A1 (en) * | 2021-12-01 | 2023-06-08 | 주식회사 휴메디솔 | Contact lens solution based on mpc and protease, and method for preparing same |
WO2023101047A1 (en) * | 2021-12-01 | 2023-06-08 | 주식회사 휴메디솔 | Protease-based contact lens cleaning solution and method for preparing same |
Also Published As
Publication number | Publication date |
---|---|
KR102163884B1 (en) | 2020-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100852944B1 (en) | Method for preparing chemically crosslinked hyaluronic acid hydrogel nanoparticles | |
Gunathilake et al. | Influence of a nonionic surfactant on curcumin delivery of nanocellulose reinforced chitosan hydrogel | |
Hao et al. | Phosphorylated zein as biodegradable and aqueous nanocarriers for pesticides with sustained-release and anti-UV properties | |
EP3738622B1 (en) | Vitamin c-containing polycaprolactone microsphere filler and preparation method therefor | |
Machado et al. | Preparation of calcium alginate nanoparticles using water-in-oil (W/O) nanoemulsions | |
US20190046429A1 (en) | Dermal filler composed of macroporous chitosan microbeads and cross-linked hyaluronic acid | |
CN102138904B (en) | Self-solidified microspheres and preparation method and application thereof | |
KR101645440B1 (en) | Manufacturing method of hydrogel mask comprising plenty of oleaginous components for skin care and hydrogel composition the same | |
JP2008517878A (en) | Method of forming shape-retaining aggregates of gel particles and use thereof | |
KR102163884B1 (en) | Spherical hydrogel particles using MPC and water-soluble crosslinking agent | |
KR101663775B1 (en) | Composition for stabilizing polyphenolic effective ingredient | |
KR101515415B1 (en) | Moisturizing patches comprising silica-containing complex nanoparticle | |
KR101032623B1 (en) | Double capsule consisting of pH-responsive copolymer and phospholipid and cosmetic composition containing same | |
US20050272922A1 (en) | Processes for preparing crosslinker-free, biopolymer-containing three dimensional structures, and products prepared thereby | |
KR101610027B1 (en) | Composition for forming hydrogel based on Pluronic having improved stabillity | |
KR100581215B1 (en) | Flavonoids / Polymer composite spheres and preparation method thereof, and cosmetic composition containing the same | |
KR101717925B1 (en) | Method for stabilizing enzyme forming cross-linked hydrogel with enzyme | |
WO2015065100A1 (en) | Spherical hydrogel particles using mpc and water-soluble crosslinking agent | |
KR102829586B1 (en) | Hyaluronic acid hydrogel with ceramide bonded thereto | |
KR102048710B1 (en) | Biodegradable fructose 1,6-bisphosphate stabilizing capsule, the method for preparing the same, and the cosmetic composition containing the same | |
EP4201437B1 (en) | Hemostatic material composition | |
EP4201438B1 (en) | Hemostatic material composition | |
KR20130041946A (en) | Oil-based gel-like composition | |
CN112120945B (en) | Water-in-water composition with high resveratrol content | |
KR100493449B1 (en) | A surface coating method of nanoparticle for cosmetic material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20141031 |
|
PG1501 | Laying open of application | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20190821 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20141031 Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200915 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20201005 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20201006 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |